MALDI-TOF mass spectrometry-based SNP genotyping

Author： Pusch Wolfgang Wurmbach Jan-Henner Thiele Herbert Kostrzewa Markus

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.3, Iss.4, 2002-07, pp. : 537-548

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Application of MALDI-TOF Mass Spectrometry in Screening and Diagnostic Research

Current Pharmaceutical Design, Vol. 11, Iss. 20, 2005-08 ,pp. : 2577-2591

Bentham Science Publishers

Access to resources Recommend Favorite

Multiplex genotyping of CYP3A4, CYP3A5, CYP2C9 and CYP2C19 SNPs using MALDI-TOF mass spectrometry

By Falzoi Matteo Mossa Alessandra Congeddu Elena Saba Luisella Pani Luca

Pharmacogenomics, Vol. 11, Iss. 4, 2010-04 ,pp. : 559-571

Future Medicine

Access to resources Recommend Favorite

MALDI-TOF mass spectrometry analysis of small molecular weight compounds (under 10 KDa) as biomarkers of rat hearts undergoing arecoline challenge

By Chen Tung-Sheng Chang Mu-Hsin Kuo Wei-Wen Lin Yueh-Min Yeh Yu-Lan Day Cecilia Hsuan Lin Chien-Chung Tsai Fuu-Jen Tsai Chang-Hai Huang Chih-Yang

Pharmaceutical Biology (Formerly International Journal of Pharmacognosy), Vol. 51, Iss. 4, 2013-04 ,pp. : 488-491

Informa Healthcare

Access to resources Recommend Favorite

Mass spectrometry-based clinical proteomics

By Pusch Wolfgang Flocco Mark T Leung Sau-Mei Thiele Herbert Kostrzewa Markus

Pharmacogenomics, Vol. 4, Iss. 4, 2003-07 ,pp. : 463-476

Future Medicine

Access to resources Recommend Favorite

Proteomic Profiling of Invasive Ductal Carcinoma (IDC) using Magnetic Beads‐based Serum Fractionation and MALDI‐TOF MS

Journal Of Clinical Laboratory Analysis (Electronic), Vol. 29, Iss. 4, 2015-07 ,pp. : 321-327

John Wiley & Sons Inc

Access to resources Recommend Favorite